Allergy Diagnostics Market | Industry Analysis Report, 2027
The global Allergy Diagnostics market gathered revenue around USD 4.0 Billion in 2020 and market is set to grow USD 10.7 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 12% during the prediction period 2021 to 2027.
Growth Factors:
The high incidence of allergic diseases and associated heavy economical burden, rising environmental pollution levels, increasing funds by organizations in allergy diagnostics, and the increasing access to healthcare insurance.
Food allergy is a growing health concern, with increasing prevalence in both developed and developing countries. According to a research study by Wenyin Loh et al., published in the International Journal of Environmental Research and Public Health, September 2018, in developed countries, food allergy has been reported to be as high as 10%, with the most prevalence witnessed among younger children. Moreover, there is an increasing prevalence of food allergies in developing countries; China and Africa are similar to developed countries in terms of the prevalence of allergies.
Therefore, with the growing burden of allergic diseases, the new diagnostic market for the same is expected to grow significantly. Furthermore, the latest diagnostic strategies for allergies and research on new treatment approaches are expected to drive the market studied over the forecast period. However, a lack of awareness about allergic diseases and affordability of allergy diagnostics are expected to restrain the market growth.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Allergy Diagnostics market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Allergy Diagnostics market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
| Report Scope | Details |
| Market Size | USD 10.7 Billion by 2027 |
| Growth Rate | CAGR of 12% From 2021 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2021 to 2027 |
| Historic Data | 2017 to 2020 |
| Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
| Segments Covered | Product & service, allergen, test type, end user, and region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | Thermo Fisher Scientific Inc., Siemens Healthineers, Danaher, Omega Diagnostics Group PLC, bioMérieux SA, Romer Labs Division Holding, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy, NEOGEN Corporation, Eurofins Scientific, Minaris Medical America, Inc. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Allergy Diagnostics market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Allergy Diagnostics Market include: Thermo Fisher Scientific Inc., Siemens Healthineers, Danaher, Omega Diagnostics Group PLC, bioMérieux SA, Romer Labs Division Holding, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy, NEOGEN Corporation, Eurofins Scientific, Minaris Medical America, Inc., Stallergenes Greer, HOB Biotech Group Corp., Ltd., HYCOR Biomedical, R-Biopharm AG , AESKU.GROUP GmbH, ACON Laboratories, Inc.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Allergy Diagnostics Market by Product & Service
Allergy Diagnostics Market by Allergen
Allergy Diagnostics Market by Test Type
Allergy Diagnostics Market by End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Allergy Diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Allergy Diagnostics market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Allergy Diagnostics markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Allergy Diagnostics market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Allergy Diagnostics Market, By Product & Service
7.1. Allergy Diagnostics Market, by Product & Service, 2021-2027
7.1.1. Consumables
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Instruments
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Services
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Allergy Diagnostics Market, By Allergen
8.1. Allergy Diagnostics Market, by Allergen, 2021-2027
8.1.1. Inhaled Allergens
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Food Allergens
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Drug Allergens
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Other Allergens
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Allergy Diagnostics Market, By Test Type
9.1. Allergy Diagnostics Market, by Test Type, 2021-2027
9.1.1. In Vivo Tests
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Skin Prick Tests
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Patch Tests
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Other In Vivo Tests
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. In Vitro Tests
9.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Allergy Diagnostics Market, By End User
10.1. Allergy Diagnostics Market, by End User, 2021-2027
10.1.1. Diagnostic Laboratories
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Hospital-based Laboratories
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Academic Research Institutes
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Other End Users
10.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Allergy Diagnostics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.1.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.1.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.1.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.2.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.2.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.2.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product & Service(2016-2027)
11.2.6.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.3.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.3.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.3.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.4.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.4.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.4.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.5.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Allergen (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End User (2016-2027)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Siemens Healthineers
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Danaher
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Omega Diagnostics Group PLC
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. bioMérieux SA
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Romer Labs Division Holding
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. EUROIMMUN Medizinische Labordiagnostika AG
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. HollisterStier Allergy
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. NEOGEN Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Eurofins Scientific
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers